Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry

Abstract

Ischemia and no obstructive coronary arteries (INOCA) is a common clinical presentation, with a variety of causes that are often not fully investigated in routine clinical practice. The goal of our study was to characterize a real-world population of patients with INOCA, with a deeper focus on symptoms and stress test findings. The study population consisted of 435 patients who underwent diagnostic coronary angiography for anginal symptoms and/or evidence of myocardial ischemia at non-invasive imaging. In all patients angiography demonstrated nonobstructive coronary artery disease (CAD, less than 30% luminal diameter stenosis or fractional flow reserve > 0.8 and/or instantaneous wave-free ratio  > 0.89). Fifty-four percent of the patients were women. Atypical clinical presentation was more common in women (59.5 vs. 49.5%, p = 0.037). Women were more likely to have normal coronary arteries than men (41.8 vs. 16.2%, p < 0.001), and less likely than men to have hemodynamically non-significant CAD (32.1 vs. 55.1%, p < 0.001). No significant correlation between typicality of symptoms and evidence of ischemia was found in those patients (244/435, 56.1%) who had either dobutamine stress echocardiography or electrocardiogram stress test. INOCA is a common clinical condition, prevalent in women often presenting with atypical symptoms.

Keywords

Ischemic heart disease - chronic coronary syndrome - INOCA - nonobstructive coronary artery disease - stress tests - atypical symptoms - heart disease in women

• References

• 1 Cook S, Walker A, Hügli O, Togni M, Meier B. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004. Clin Res Cardiol 2007; 96 (06) 375-382
• 2 Patel MR, Peterson ED, Dai D. et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010; 362 (10) 886-895
• 3 Herscovici R, Sedlak T, Wei J, Pepine CJ, Handberg E, Bairey Merz CN. Ischemia and no obstructive coronary artery disease (INOCA): what is the risk?. Circulation 2017; 135 (11) 1075-1092
• 4 Gulati M, Shaw LJ, Bairey Merz CN. Myocardial ischemia in women: lessons from the NHLBI WISE study. Clin Cardiol 2012; 35 (03) 141-148
• 5 Jespersen L, Hvelplund A, Abildstrøm SZ. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012; 33 (06) 734-744
• 6 Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease. Circulation 2018; 138 (14) 1463-1480
• 7 Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38 (03) 199-210
• 8 Khuddus MA, Pepine CJ, Handberg EM. et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol 2010; 23 (06) 511-519
• 9 Iqbal SN, Feit F, Mancini GBJ. et al. Characteristics of plaque disruption by intravascular ultrasound in women presenting with myocardial infarction without obstructive coronary artery disease. Am Heart J 2014; 167 (05) 715-722
• 10 Maas A. Characteristic symptoms in women with ischemic heart disease. Curr Cardiovasc Risk Rep 2019; 13 (07) 17 . Doi: 10.1007/s12170-019-0611-3
• 11 Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356 (08) 830-840
• 12 Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008; 51 (01) 2-17
• 13 Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci 2012; 4 (01) 65-93
• 14 Dewey M, Hamm B. Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease. Eur Radiol 2007; 17 (05) 1301-1309
• 15 Boden WE, O'Rourke RA, Teo KK. et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356 (15) 1503-1516
• 16 Crea F, Bairey Merz CN, Beltrame JF. et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J 2019; 40 (29) 2455-2462
• 17 Sharma S, Mehta PK, Arsanjani R. et al. False-positive stress testing: does endothelial vascular dysfunction contribute to ST-segment depression in women? A pilot study. Clin Cardiol 2018; 41 (08) 1044-1048
• 18 Ong P, Athanasiadis A, Hill S, Schäufele T, Mahrholdt H, Sechtem U. Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries. Clin Cardiol 2014; 37 (08) 462-467
• 19 Nihoyannopoulos P, Kaski JC, Crake T, Maseri A. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991; 18 (06) 1463-1470
• 20 Al-Lamee R, Thompson D, Dehbi HM. et al. ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 2018; 391 (10115): 31-40
• 21 Al-Lamee R, Howard JP, Shun-Shin MJ. et al. Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease. Circulation 2018; 138 (17) 1780-1792